Perrigo completes divestiture of generic Rx business for $1.55 billion
Perrigo CEO and President Murray S. Kessler commented, "Closing this transaction was another important milestone for Perrigo's transformation.
"We are now a leading pure-play global consumer self-care company that has significant resources to invest and has a passionate and committed team that is dedicated to making our vision a reality – To make lives better by bringing quality affordable self-care products consumers trust, everywhere they are sold. I am more excited than ever about the company's future."
Kessler concluded, "I would like to thank the Rx team for their dedication throughout this process and I am confident that they will continue to be successful in their mission of developing, manufacturing and distributing high quality, affordable healthcare products." ■